Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV

Clinical Endocrinology

Volumn 76, Issue 2, 2012, Pages 201-206

  Hammond, E ^a   McKinnon, E ^a   Glendenning, P ^b,c   Williams, R ^b   Mallal, S ^a   Phillips, E ^a  

^a MURDOCH UNIVERSITY   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ADIPONECTIN; EFAVIRENZ; INSULIN; NEVIRAPINE; PROTEINASE INHIBITOR; STAVUDINE; THYMIDINE DERIVATIVE; VITAMIN D RECEPTOR; ZIDOVUDINE;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY FAT; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPOATROPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VITAMIN D DEFICIENCY;

ADULT; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HUMANS; INSULIN; LIPODYSTROPHY; MALE; MIDDLE AGED; VITAMIN D;

EID: 84855461392     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04149.x     Document Type: Article

References (20)

1. Hammond, E., McKinnon, E., &, Nolan, D., (2010) Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences. Clinical Infectious Disease, 51, 591-599.
2. Addy, C.L., Gavrila, A., Tsiodras, S., et al. (2003) Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. Journal of Clinical Endocrinology and Metabolism, 88, 627-636. (Pubitemid 36207802)
3. Samaras, K., Wand, H., Law, M., et al. (2007) A Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Diabetes Care, 30, 113-119. (Pubitemid 46052508)
4. Liu, E., Meigs, J.B., Pittas, A.G., et al. (2009) Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. Journal of Nutrition, 139, 329-334.
5. Bell, N.H., Epstein, S., Greene, A., et al. (1985) Evidence for alteration of the vitamin D-endocrine system in obese subjects. Journal of Clinical Investigation, 76, 370-373. (Pubitemid 15243466)
6. Snijder, M.B., van Dam, R.M., Visser, M., et al. (2005) Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. Journal of Clinical Endocrinology Metabolism, 90, 4119-4123. (Pubitemid 41058184)
7. de Luis, D.A., Aller, R., Romero, E., et al. (2010) Relation of phase angle tertiles with blood adipocytokines levels, insulin resistance and cardiovascular risk factors in obese women patients. European Review of Medical Pharmacology Science, 14, 521-526.
8. Holst-Schumacher, I., Nuñez-Rivas, H., Monge-Rojas, R., et al. (2009) Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren. Food Nutrition Bulletin, 30, 161-170.
9. Forouhi, N.G., Luan, J., Cooper, A., et al. (2008) Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes, 57, 2619-2625.
10. Van Den Bout-Van Den Beukel, C.J., Fievez, L., Michels, M., et al. (2008) Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Research Human Retrovirus, 24, 1375-1382.
11. Mueller, N.J., Fux, C.A., Ledergerber, B., et al. (2010) The Swiss HIV Cohort Study. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS, 24, 1127-1134.
12. Nimitphong, H., Chanprasertyothin, S., Jongjaroenprasert, W., et al. (2009) The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine, 36, 205-210.
13. Gannagé-Yared, M.H., Chedid, R., Khalife, S., et al. (2009) Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. European Journal of Endocrinolology, 160, 965-971.
14. Glendenning, P., Taranto, M., Noble, J.M., et al. (2006) Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays. Annals of Clinical Biochemistry, 43, 23-30. (Pubitemid 43105054)
15. Hammond, E., McKinnon, E., Mallal, S., et al. (2008) Longitudinal evaluation of cardiovascular disease-associated biomarkers in relation to abacavir therapy. AIDS, 22, 2540-3254.
16. Fox, J., Peters, B., Prakash, M., et al. (2010) Improvement in vitamin D deficiency following antiretroviral regime change: results from the MONET trial. Aids Research and Human Retroviruses, 27, 29-34.
17. Herzmann, C., &, Arasteh, K., (2009) Efavirenz-induced osteomalacia. AIDS, 23, 274-276.
18. Welz, T., Childs, K., Ibrahim, F., et al. (2010) Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS, 24, 1923-1928.
19. Ellfolk, M., Norlin, M., Gyllensten, K., et al. (2009) Regulation of human vitamin D3 25-hydroxylast in dermal fibroblasts and prostate cancer LNCaP cells. Molecular Pharmacology, 75, 1392-1399.
20. Clemens, T.L., &, Karnesty, G., (2011) The osteoblast: an insulin target cell controlling glucose homeostasis. Journal of Bone and Mineral Research, 26, 677-680.